872-17-3

Applied Filters:

Keyword:'872-17-3'

Showing 1-3 of 3 results for "872-17-3" within Papers

Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).

Ksenia Goryachkina et al.

European journal of clinical pharmacology, 64(3), 275-282 (2007-11-29)

To investigate the influence of paroxetine on metoprolol concentrations and its effect in patients treated for acute myocardial infarction (AMI) who are routinely given paroxetine as a co-treatment of depression. We recruited 17 depressed AMI patients who received metoprolol as

Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.

Thomas Horvatits et al.

Pathogens (Basel, Switzerland), 9(9) (2020-09-20)

Hepatitis E virus (HEV) has been associated with immunological phenomena. Their clinical significance, however, still needs to be clarified, that is, whether cryoglobulins or autoantibodies impact overt disease in HEV-infected individuals. To better understand, we analyzed these different immune phenomena

Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.

Barbara Grün et al.

British journal of clinical pharmacology, 74(5), 854-863 (2012-03-03)

The analgesic activity of tilidine is mediated by its active metabolite, nortilidine, which easily penetrates the blood-brain barrier and binds to the µ-opioid receptor as a potent agonist. Tilidine undergoes an extensive first-pass metabolism, which has been suggested to be

Page 1 of 1